SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: September 30, 2003
CANTEL MEDICAL CORP.
(Exact name of registrant as specified in its Charter)
Delaware |
| 001-31337 |
| 22-1760285 |
(State or other jurisdiction |
| (Commission |
| (IRS Identification |
|
|
|
|
|
150 Clove Road, Little Falls, New Jersey |
| 07424 | ||
Address of principal executive offices) |
| (Zip Code) | ||
|
|
|
|
|
Registrant’s telephone number, including area code: (973) 890-7220 | ||||
|
|
|
|
|
|
|
|
|
|
(Former name or former address, if changed since last report) | ||||
Item 12. Results of Operations and Financial Condition
On September 30, 2003, the Registrant issued a press release announcing its results of operations for the fiscal year and quarter ended July 31, 2003. A copy of the press release is included with this Report as Exhibit 99(l).
Item 7. Financial Statements, Pro-Forma Financial Information and Exhibits
(c) Exhibit 99(l). Press release of Cantel Medical Corp. dated September 30, 2003.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CANTEL MEDICAL CORP. | |||
|
| |||
|
| |||
| By: | /s/ James P. Reilly |
| |
| James P. Reilly, | |||
| President and Chief Executive Officer | |||
|
| |||
Dated: | October 2, 2003 |
| ||
3
